HIV and the central nervous system

Comprehensive Therapy

Volumn 28, Issue 1, 2002, Pages 23-33

  Bensalem, Meriem K ^a   Berger, Joseph R ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIRETROVIRUS AGENT; ANTIVIRUS AGENT; FLUCONAZOLE; FLUCYTOSINE; FOSCARNET; GANCICLOVIR; METHOTREXATE; PENICILLIN DERIVATIVE; PYRIMETHAMINE; SULFADIAZINE; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CENTRAL NERVOUS SYSTEM; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CYTOMEGALOVIRUS INFECTION; DEMENTIA; ENCEPHALITIS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOMA; MENINGITIS; NEUROLOGICAL COMPLICATION; NEUROSYPHILIS; PATHOPHYSIOLOGY; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; TOXOPLASMOSIS;

EID: 0036198937     PISSN: 00988243     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12019-002-0039-3     Document Type: Article

References (120)

1. Lymphadenopathy associated virus and its etiological role in AIDS
2. Isolation of human T-cell leukemia virus in acquired immune deficiency syndrome (AIDS)
3. Neurologic disease as the presenting manifestation of acquired immunodeficiency syndrome
4. Neurological manifestations of the acquired immunodeficiency syndrome (AIDS): Experience at UCSF and review of the literature
5. Neurological complications of acquired immune deficiency syndrome: Analysis of 50 patients
6. The neuropathology of the acquired immune deficiency syndrome (AIDS). A review
7. Human immunodeficiency virus-1 infection of the nervous system: An autopsy study of 268 adult, pediatric, and fetal brains
8. Survival differences in patients with AIDS
9. Trends and survival for AIDS patients presenting with indicative neurologic disease
10. Improved survival from diagnosis of AIDS in adult cases in the United Kingdom and bias due to reporting delays
11. Pediatric acquired immunodeficiency syndrome. Neurologic syndromes
12. Comparison of simian immunodeficiency virus and human immunodeficiency virus encephalitides in the immature host
13. Epidemiology of human immunodeficiency virus encephalopathy in the United States
14. Incidence of AIDS dementia in a two-year follow-up of AIDS and ARC patients on an initial phase II AZT placebo-controlled study: San Diego cohort
15. Temporal trends in the incidence of HIV-1-related neurologic diseases: Multicenter AIDS Cohort Study, 1985-1992
16. Pathobiology of human immunodeficiency virus dementia
17. Cerebrospinal fluid human immunodeficiency virus type 1 RNA levels are elevated in neurocognitively impaired individuals with acquired immunodeficiency syndrome
18. Infection of brain microglial cells by human immunodeficiency virus type 1 is CD4 dependent
19. HIV-1 proviral DNA load across neuroanatomic regions of individuals with evidence for HIV-1-associated dementia
20. Distribution of brain HIV load in AIDS
21. The AIDS dementia complex: II. Neuropathology
22. A review of neuronal damage in human immunodeficiency virus infection: Its assessment, possible mechanism and relationship to dementia
23. Assessment of neuronal density in the putamen in human immunodeficiency virus (HIV) infection. Application of stereology and spatial analysis of quadrats
24. Selective neuronal vulnerability in HIV encephalitis
25. The AIDS dementia complex: I. Clinical features
26. Reduced basal ganglia volume in HIV-1-associated dementia: Results from quantitative neuroimaging
27. HIV-1-associated cognitive/motor complex: Absence of neuronal loss in the cerebral neocortex
28. The clinical psychiatry of AIDS
29. CT, MR, and pathology in HIV encephalitis and meningitis
30. Neuropsychological outcome of zidovudine (AZT) treatment of patients with AIDS and AIDS-related complex
31. Effect of continuous intravenous infusion of zidovudine (AZT) in children with symptomatic HIV infection
32. Declining incidence of AIDS dementia complex after introduction of zidovudine treatment
33. Incidence and prevalence of neurological disorders associated with HIV since the introduction of highly active antiretroviral therapy (HAART)
34. HIV-associated neurologic disease incidence changes: Multicenter AIDS Cohort Study, 1990-1998
35. Highly active antiretroviral therapy reverses brain metabolite abnormalities in mild HIV dementia
36. Multifocal cytomegalovirus encephalitis in AIDS
37. Human immunodeficiency virus-associated dementia
38. Progressive multifocal leukoencephalopathy associated with human immunodeficiency virus infection. A review of the literature with a report of sixteen cases
39. Progressive multifocal leukoencephalopathy in patients with HIV infection
40. Relation of JC virus DNA in the cerebrospinal fluid to survival in acquired immunodeficiency syndrome patients with biopsy-proven progressive multifocal leukoencephalopathy
41. Predictive factors for prolonged survival in acquired immunodeficiency syndrome-associated progressive multifocal leukoencephalopathy
42. Progressive multifocal leukoencephalopathy
43. Ophthalmologic manifestations of acquired immune deficiency syndrome-associated progressive multifocal leucoencephalopathy
44. Progressive multifocal leukoencephalopathy
45. Progressive multifocal leukoencephalopaghy in 47 HIV positive patients: Neuroimaging with clinical and pathologic correlation
46. JC virus detection in the cerebrospinal fluid of AIDS patients with progressive multifocal leukoencephalopathy and monitoring of the antiviral treatment by PCR method
47. Epidemiology of non-infective bowel diseases in South African populations
48. Opportunistic viral infections in the setting of human immunodeficiency virus
49. Cytomegalic inclusion virus encephalitis in patients with AIDS: CT, clinical, and pathologic correlation
50. Cytomegalovirus in the nervous system of patients with the acquired immune deficiency syndrome
51. Cytomegalovirus encephalitis in acquired immunodeficiency syndrome (AIDS)
52. Role of HIV and CMV in the pathogenesis of retinitis and retinal vasculopathy in AIDS patients
53. Choroid plexus infection in cerebral toxoplasmosis in AIDS patients
54. Cytomegalovirus ventriculoencephalitis in AIDS. A syndrome with distinct clinical and pathologic features
55. Induction and maintenance therapy of cytomegalovirus central nervous system infection in HIV-infected patients
56. Toxoplasmic encephalitis in patients with acquired immune deficiency syndrome
57. Cerebral toxoplasmosis complicating the acquired immune deficiency syndrome: Clinical and neuropathological findings in 27 patients
58. Toxoplasmosis of the central nervous system in the acquired immunodeficiency syndrome
59. Movement disorders and AIDS
60. Toxoplasma encephalitis in Haitian adults with acquired immunodeficiency syndrome: A clinicalpathologic-CT correlation
61. Toxoplasma encephalitis in Haitian adults with acquired immunodeficiency syndrome: A clinical-pathologic-CT correlation
62. Neurologic manifestations of AIDS
63. Acquired immunodeficiency syndrome. Magnetic resonance patterns of brain involvement with pathologic correlation
64. CNS toxoplasmosis in acquired immune deficiency syndrome: A clinical-pathological-radiological review of 12 cases
65. Evaluation of the policy of empiric treatment of suspected Toxoplasma encephalitis in patients with the acquired immunodeficiency syndrome
66. Toxoplasmic encephalitis in AIDS
67. Assessment of therapy for Toxoplasma encephalitis
68. AIDS-associated primary central nervous system lymphoma
69. Primary central nervous system lymphoma in acquired immune deficiency syndrome: A clinical and pathological study
70. Neuroepidemiology of acquired immunodeficiency syndrome
71. Lymphoma related to human immunodeficiency virus: The epidemic shifts
72. Development of non-Hodgkin lymphoma in a cohort of patients with severe human immunodeficiency virus (HIV) infection on longterm antiretroviral therapy
73. Epstein-Barr virus in AIDS-related primary central nervous system lymphoma
74. Primary central nervous system lymphomas in patients with AIDS
75. Primary central nervous system lymphoma: CT and pathologic correlation
76. Use of thallium-201 brain SPECT to differentiate cerebral lymphoma from Toxoplasma encephalitis in AIDS patients
77. Evaluation of contrast-enhancing brain lesions in AIDS patients by means of Epstein-Barr virus detection in cerebrospinal fluid and 201thallium single photon emission tomography
78. The role of stereotactic biopsy in the management of HIV-related focal brain lesions
79. The stereotactic biopsy diagnosis of focal intracerebral lesions in AIDS patients
80. Stereotactic brain biopsy in AIDS
81. Primary central nervous system lymphomas: Natural history and response to radiation therapy in 55 patients with acquired immunodeficiency syndrome
82. Primary central nervous system lymphoma in homosexual men. Clinical, immunologic, and pathologic features
83. Primary central nervous system lymphoma in patients with and without the acquired immune deficiency syndrome. A retrospective analysis and review of the literature
84. 3′-azido 3′-deoxythymidine + methotrexate as a novel antineoplastic combination in the treatment of human immunodeficiency virus-related non-Hodgkin's lymphomas
85. Impact of potent antiretroviral therapy on the incidence of Kaposi's sarcoma and non-Hodgkin's lymphomas among HIV-1-infected individuals. Multicenter AIDS Cohort Study
86. Cerebrovascular disease in AIDS: A case-control study
87. Cerebrovascular disease in young, HIV-infected, black Africans in the KwaZulu Natal province of South Africa
88. Cerebral infarction in adult AIDS patients: Observations from the Edinburgh HIV Autopsy Cohort
89. Primary human T-lymphotropic virus type III infection
90. Acute AIDS retrovirus infection. Definition of a clinical illness associated with seroconversion
91. Acute encephalopathy coincident with seroconversion for anti-HTLV-III
92. Spectrum of cerebrospinal fluid findings in various stages of human immunodeficiency virus infection
93. Cryptococcal meningitis in patients with AIDS
94. Cryptococcosis and AIDS
95. Nonviral infections of the central nervous system in patients with acquired immunodeficiency syndrome
96. Cryptococcal meningitis and AIDS
97. Mycobacterial spinal cord abscess with an ascending polyneuropathy
98. CT of intracranial cryptococcosis
99. Cryptococcal disease in patients with the acquired immunodeficiency syndrome. Diagnostic features and outcome of treatment
100. Fluconazole compared with amphotericin B plus flucytosine for cryptococcal meningitis in AIDS. A randomized trial
101. Treatment of cryptococcal meningitis with combination amphotericin B and flucytosine for four as compared with six weeks
102. Comparison of amphotericin B with fluconazole in the treatment of acute AIDS-associated cryptococcal meningitis
103. Itraconazole compared with amphotericin B plus flucytosine in AIDS patients with cryptococcal meningitis
104. Amphotericin B-associated leukoencephalopathy
105. Experience with liposomal amphotericin B (AmBisome) in cryptococcal meningitis in AIDS
106. Persistent Cryptococcus neoformans infection of the prostate after successful treatment of meningitis
107. Tuberculosis in patients with the acquired immunodeficiency syndrome. Clinical features, response to therapy, and survival
108. Central nervous system tuberculosis with the acquired immunodeficiency syndrome and its related complex
109. Tuberculous meningitis with ascellular cerebrospinal fluid in AIDS patients
110. Spinal cord toxoplasmosis in AIDS
111. Neuropathology of acquired immunodeficiency syndrome
112. Neurosyphilis in human immunodeficiency virus type 1-seropositive individuals. A prospective study
113. Cerebrospinal fluid abnormalities in 170 cases of AIDS
114. Diagnosising neurosyphilis: The value of the cerebrospinal fluid VDRL or lack thereof
115. Alteration in the natural history of neurosyphilis by concurrent infection with the human immunodeficiency virus
116. Invasion of the central nervous system by Treponema pallidum: Implications for diagnosis and treatment
117. Syphilis, neurosyphilis, penicillin, and AIDS
118. Secondary syphilis and HIV infection
119. Neurosyphilis in acquired immunodeficiency syndrome